Indivior (LON:INDV) Shares Down 15.7% – What’s Next?

Indivior PLC (LON:INDV) fell 15.7% during trading on Thursday . The company traded as low as GBX 548.71 ($6.95) and last traded at GBX 732 ($9.28). 1,888,371 shares changed hands during trading, an increase of 166% from the average session volume of 709,477 shares. The stock had previously closed at GBX 868 ($11.00).

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group reissued a “buy” rating and issued a GBX 1,800 ($22.81) price objective on shares of Indivior in a report on Tuesday, December 17th.

Indivior Stock Performance

The company has a market capitalization of £1.14 billion, a P/E ratio of -606.93, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The company’s fifty day moving average is GBX 924.76 and its 200 day moving average is GBX 852.88.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.